Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
NEW YORK , Sept. 26, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Edwards Li
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corp
East West Petroleum Provides Update on Special Distribution, Name Change and Consolidation
05:00pm, Monday, 22'nd Sep 2025
Vancouver, British Columbia--(Newsfile Corp. - September 22, 2025) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") wishes to provide an update on the capital reduction and specia
East West Petroleum Announces Name Change and Consolidation
07:00am, Wednesday, 17'th Sep 2025
Vancouver, British Columbia--(Newsfile Corp. - September 17, 2025) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") announces that it intends to change the Company's name from "
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Edwards (EW) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Edwards
East West Petroleum Provides Update on Special Distribution
07:00am, Thursday, 11'th Sep 2025
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2025) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to provide an update with respect to its previously
East West Petroleum Shareholders Approve Capital Reduction and All Other Matters at the Annual and Special Meeting
04:30pm, Friday, 05'th Sep 2025
Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to announce that at the Annual and Special Meeting of
3 Healthcare Pathbreakers With Long-Term Tailwinds
12:21pm, Monday, 01'st Sep 2025
In the world of healthcare stocks, a major innovation, new medical device, or successful drug treatment can cement a firm's position as a leader. Unfortunately, many firms chase after these goals and
ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now?
10:50am, Friday, 29'th Aug 2025
Investors are showing growing interest in the rapidly expanding structural heart device market, which is expected to witness a compound annual growth rate (CAGR) of 13.5% between 2025 and 2033, accord
Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care
09:09am, Friday, 29'th Aug 2025
MADRID--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) welcomes the updated ESC/EACTS guidelines for valvular heart disease, which establish a simplified care pathway for all severe aortic stenosis
Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase
04:15pm, Tuesday, 19'th Aug 2025
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement ("ASR") to repurchase $500 million of Edwards' common st
Edwards Lifesciences Corporation Investors: Company Investigated by the Portnoy Law Firm
04:16pm, Thursday, 14'th Aug 2025
Investors can contact the law firm at no cost to learn more about recovering their losses
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Edwards (EW) To Contact Him Directly To Discuss Their Options
Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025
09:45pm, Thursday, 07'th Aug 2025
We added key positions in Masimo, Exact Sciences, Eli Lilly, Penumbra, and Edwards Lifesciences, each with strong growth drivers and market leadership. Our investment in Masimo is supported by divesti
JenaValve Responds to FTC's Action Against Proposed Edwards Lifesciences Acquisition
02:17pm, Wednesday, 06'th Aug 2025
IRVINE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology announced today that the U.S. Federal Trade Commission (FTC) moved to block the company's proposed acquisition by Edwards Lifesci
